TCTR20220928006已完成不适用
FLT3 Gene Mutations among Acute Myeloid Leukemia patients in Northeast Thailand
/A0 个研究点目标入组 65 人开始时间: 2022年9月28日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 65
研究概览
简要总结
Frequencies of FLT3-ITD and TKD were found to be 16.9% (11/65) and 10.8% (7/65), respectively. The WBC and peripheral blast percentage of FLT3-ITD positive patients were statistically significantly higher than those of the FLT3-wild type patients, while the peripheral blast percentage of FLT3-TKD positive patients was significantly lower. No other clinical characteristics among FLT3 positive and FLT3-wild type patients were observed.DNA sequencing identified 4 FLT3-TKD mutations.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- N/A (No limit) 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •all newly diagnosed AML patients between January 2020 and May 2021
排除标准
- 未提供
研究者
相似试验
Unknown
不适用
Development of a Diagnostic Kit for FLT3-ITD in Acute Myeloid LeukemiaAcute Myeloid LeukemiaNCT01141673Taipei Medical University WanFang Hospital100
进行中（未招募）
3 期
A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive ChemotherapyMyelodysplastic Syndrome With Excess Blasts-2Acute Myeloid LeukemiaNCT04027309Stichting Hemato-Oncologie voor Volwassenen Nederland777
招募中
1 期
The Efficacy of Triple Regimen in Newly Diagnosed AML Patients With FLT3 MutationFLT3 Gene MutationAMLNCT06561880Institute of Hematology & Blood Diseases Hospital, China66
Unknown
不适用
FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid Leukemia.Acute Myeloid LeukemiaNCT05383014Assiut University82
招募中
不适用
Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic TreatmentsMyeloid Leukemia, AcuteNCT06764459IRCCS Azienda Ospedaliero-Universitaria di Bologna20